NOVT

Novanta Inc

NOVT.US novanta.com + Research + Basket
CIK 0001076930
ISIN CA67000B1040
CUSIP 36191C106
Employees 3,000
Phone 781 266 5700
Fiscal year end December
IPO Jan 04, 2016
Address 125 Middlesex Turnpike, Bedford, MA, United States, 01730
131.82
-13.41 (-9.23%)
USD · NASDAQ
52-week range
98.27
176.38
Trading at 43% of the 52-week range
Market Cap
5.49B
P/E Ratio
91.92
Forward P/E
8.39
Book Value
42.75
Div. Yield
N/A
% Institutions
122.42%
% Insiders
0.707%

1 Year

-0.5%

3 Year

-4.8%

10 Year

+657.6%
Description

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

Actions

Add an action for NOVT.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Matthijs Glastra CEO & Chairman of the Board 1969
Mr. Robert J. Buckley Chief Financial Officer 1974
Mr. Alexander Manganiello General Counsel & Corporate Secretary 1967
Mr. Charles G. Ravetto Co-Chief Operating Officer of Automation Enabling Technologies 1971
Mr. John Lesica Co-Chief Operating Officer of Medical Solutions 1976
Mr. John Joseph Burke II Chief Accounting Officer & Corporate Controller 1982
Ms. Sarah Betadam Chief Information Officer & Chief Information Security Officer NA
Ms. Nissia Sabri Senior Vice President of Corporate Development NA
Mr. Liam Weston Chief Human Resources Officer NA
Mr. Heinrich Dreyer Group President of Medical Solutions NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 17, 2026 Matthijs Glastra N/A Sale 6.50K $130.05 $845.33K SEC
Mar 16, 2026 Robert Buckley N/A Sale 9.96K $116.77 $1.16M SEC
Feb 20, 2026 Robert Buckley N/A Sale 1.42K $140.88 $200.47K SEC
Feb 10, 2026 Matthijs Glastra N/A Sale 7.50K $145.04 $1.09M SEC
Jan 21, 2026 Matthijs Glastra N/A Sale 7.50K $140.00 $1.05M SEC
Jan 21, 2026 Robert Buckley N/A Sale 1.42K $140.14 $199.42K SEC
Jan 09, 2026 Matthijs Glastra N/A Sale 6.18K $130.00 $803.01K SEC
Jan 08, 2026 Matthijs Glastra N/A Sale 323.00 $130.14 $42.04K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 4.80M Jun 30, 2026 12.69% $0.01 3.08%
Vanguard Portfolio Management, LLC 2.40M Jun 30, 2026 6.33% $0.02 -3.28%
T. Rowe Price Associates, Inc. 2.22M Jun 30, 2026 5.88% $0.04 24.55%
Allspring Global Investments Holdings, LLC 1.82M Jun 30, 2026 4.81% $0.46 2.30%
Vanguard Capital Management, LLC 1.61M Jun 30, 2026 4.25% $0.01 -0.39%
State Street Corp 1.44M Jun 30, 2026 3.80% $0.01 7.29%
Conestoga Capital Advisors, LLC 1.22M Jun 30, 2026 3.22% $4.30 -15.99%
Geode Capital Management, LLC 987.73K Jun 30, 2026 2.61% $0.01 5.42%
Congress Asset Management Company, LLP 973.77K Jun 30, 2026 2.57% $0.97 7.04%
GW&K Investment Management, LLC 897.27K Jun 30, 2026 2.37% $1.14 4.50%
BAMCO Inc 850.49K Jun 30, 2026 2.25% $0.21 -7.06%
William Blair Investment Management, LLC 765.87K Jun 30, 2026 2.03% $0.37 -2.20%
Wasatch Advisors LP 759.99K Jun 30, 2026 2.01% $0.81 -23.75%
Geneva Capital Management 758.88K Jun 30, 2026 2.01% $2.82 -18.51%
American Century Companies Inc 717.29K Jun 30, 2026 1.90% $0.05 3.47%
JPMorgan Chase & Co 688.71K Jun 30, 2026 1.82% $0.01 7.08%
Schroder Investment Management Group 685.75K Jun 30, 2026 1.81% $0.08 37.13%
Dimensional Fund Advisors, Inc. 665.52K Jun 30, 2026 1.76% $0.02 5.34%
Delaware Management Holdings Inc 646.60K Jun 30, 2026 1.71% $0.16 -2.20%
Mawer Investment Management Ltd 589.57K Jun 30, 2026 1.56% $0.65 22.27%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Mid-Cap ETF 1.36M 3.59% ▲ 0.09% Oct 29, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 1.20M 3.18% ▲ 6.01% Sep 30, 2026
3 iShares Russell 2000 ETF 918.71K 2.43% ▼ 0.41% Oct 29, 2026
4 Vanguard Small Cap Index 850.64K 2.25% ▲ 3.79% Sep 30, 2026
5 Vanguard Information Technology ETF 729.56K 1.93% ▲ 0.23% Sep 30, 2026
6 T. Rowe Price Mid-Cap Value 676.77K 1.79% ▲ 0.00% Sep 30, 2026
7 Allspring Special Mid Cap Value Inst 519.20K 1.37% ▲ 0.00% Sep 30, 2026
8 Vanguard MStar Small Cap Growth Indx Inv 474.09K 1.25% ▲ 0.74% Sep 30, 2026
9 American Century Small Cap Growth Inv 453.49K 1.20% ▼ 1.22% Sep 30, 2026
10 Nomura Mid Cap Growth A 417.36K 1.10% ▼ 3.14% Aug 31, 2026

Financial Highlights

▼
Market Cap: $5.49B
EBITDA: $180.95M
P/E Ratio: $91.92
PEG Ratio: $2.11
Book Value: $42.75
Earnings/Share: $1.58
Profit Margin: 6.00%
Operating Margin: 11.50%
ROA (TTM): 4.09%
ROE (TTM): 5.11%
Revenue (TTM): $1.03B
Revenue/Share (TTM): $26.45
Earnings Growth (YOY): 150.00%
Revenue Growth (YOY): 10.30%

Valuation Metrics

Enterprise Value: $5.15B
Trailing P/E: 91.92
Forward P/E: 8.39

Shares Statistics

Shares Outstanding: 37.82M
Shares Float: 37.54M
% Insiders: 0.707%
% Institutions: 122.42%
Shares Short: 5.24M
Shares Short (Prior Month): 5.14M
Short Ratio: 11.51
Short % Float: 15.92%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$980.60M
Cost of Goods Sold
adjust
$-572.79M
Gross Profit
subtotal
$407.81M
SG&A
adjust
$-195.66M
R&D
adjust
$-95.48M
Operating Income
subtotal
$116.66M
Other / Non-Operating Items
adjust
$-62.84M
Net Income
subtotal
$53.83M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NOVT.US!